Publications by authors named "Hans-Joerg Martus"

17 Publications

  • Page 1 of 1

Derisking Drug-Induced Carcinogenicity for Novel Therapeutics.

Trends Cancer 2016 08 30;2(8):398-408. Epub 2016 Jul 30.

Preclinical Safety, Translational Medicine, Novartis Institutes for BioMedical Research, Basel CH-4057, Switzerland.

View Article and Find Full Text PDF
August 2016

Compilation and use of genetic toxicity historical control data.

Mutat Res 2011 Aug 8;723(2):87-90. Epub 2010 Oct 8.

Biosafety Research Center, Foods, Drugs and Pesticides, Iwata, Japan.

View Article and Find Full Text PDF
August 2011

Strategy for genotoxicity testing--metabolic considerations.

Mutat Res 2007 Feb 1;627(1):59-77. Epub 2006 Dec 1.

Pfizer Global Research and Development, Drug Safety Research and Development, Groton, CT 06340, USA.

View Article and Find Full Text PDF
February 2007

Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micronucleus test.

Mutat Res 2006 Sep 7;607(2):153-9. Epub 2006 Jul 7.

Safety Assessment and Profiling, Exploratory Development, Novartis Pharma AG, MUT-2881.2.35, CH4002 Basel, Switzerland.

View Article and Find Full Text PDF
September 2006

Structure-activity considerations and in vitro approaches to assess the genotoxicity of 19 methane-, benzene- and toluenesulfonic acid esters.

Mutat Res 2005 Mar 21;581(1-2):23-34. Epub 2004 Dec 21.

Preclinical Safety Europe, Novartis Pharma AG, MUT-2881.2.29, CH 4002 Basel, Basel, Switzerland.

View Article and Find Full Text PDF
March 2005

Treatment and sampling protocols for transgenic mutation assays.

Environ Mol Mutagen 2003 ;41(1):1-6

Department of Biology, York University, Toronto, Ontario M3J 1P3, Canada.

View Article and Find Full Text PDF
March 2003